Anivive Announces Positive Study Results for Antifungal Vaccine to Prevent Canine Valley Fever

LOS ANGELES: LOS ANGELES, June 17, 2021 /PRNewswire/ -- Anivive, a pet health technology company transforming the therapeutic discovery and development process, today announced positive results from a study on its groundbreaking fungal vaccine for Valley Fever in dogs. The primary endpoint of the study was met, with the vaccine...

Click to view original post